Esperion Therapeutics
ESPR
#6169
Rank
โ‚น79.43 B
Marketcap
โ‚น335.09
Share price
-1.58%
Change (1 day)
18.47%
Change (1 year)

Esperion Therapeutics (ESPR) - Net assets

Net assets on the balance sheet as of September 2025 : -โ‚น40.55 Billion

According to Esperion Therapeutics's latest financial reports the company has -โ‚น40.55 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Esperion Therapeutics - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$-โ‚น33.35 Billion-11.96%
2023-12-31$-โ‚น37.88 Billion41.37%
2022-12-31$-โ‚น26.8 Billion82.78%
2021-12-31$-โ‚น14.66 Billion108.5%
2020-12-31$-โ‚น7.04 Billion-594.19%
2019-12-31$โ‚น1.42 B-74.28%
2018-12-31$โ‚น5.53 B-64.59%
2017-12-31$โ‚น15.62 B0.57%
2016-12-31$โ‚น15.53 B-18.62%
2015-12-31$โ‚น19.08 B125.53%
2014-12-31$โ‚น8.46 B84.92%
2013-12-31$โ‚น4.57 B-580.74%
2012-12-31$-โ‚น0.96 Billion197.17%
2011-12-31$-โ‚น0.33 Billion
2002-12-31$โ‚น1.85 B-42.1%
2001-12-31$โ‚น3.20 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Ultragenyx Pharmaceutical
RARE
โ‚น1.45 B-103.58%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น544.11 B-1,441.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น8.363 T-20,725.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น2.781 T-6,958.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚น20.70 B-151.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
โ‚น10.79 B-126.62%๐Ÿ‡บ๐Ÿ‡ธ USA